Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients

NCT05234190 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Rejection; Transplant, Liver
Liver Failure
Liver Diseases

Interventions

DRUG: QEL-001

Sponsor

Quell Therapeutics Limited